Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Mansoura University, Mansoura, DK, Egypt
UZ Brussel, Jette, Brussel, Belgium
Anästhesiologische Klinik (Universitätsklinikum Heidelberg), Heidelberg, Baden-Würtemberg, Germany
Moscow Scientific Clinical Center, Moscow, Russian Federation
National cancer institute, Cairo, Egypt
Karadeniz Technical University, Trabzon, Turkey
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Sir Ganga Ram Hospital, New Delhi, India
Alberta Children's Hospital, Calgary, Alberta, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.